The neurologists and neuroscientists behind every decision
Your manuscript is handled by named experts in clinical and translational neurology: a board of 18 researchers and clinicians across 8 countries, led by a subject Editor-in-Chief.
Editor-in-Chief
Zheng Jiang
Assistant Professor, Baylor College of Medicine, Houston, Texas
Electrophysiology, Retina, Neural circuitry, Synaptic transmission, Ion channels, G-protein coupled receptor, Second messengers; Calcium imaging.
<p>Zheng Jiang is an Assistant Professor at Baylor College of Medicine in Houston, Texas, United States. He earned his M.D. in Medicine from China Medical University, Shen-Yang, China (1998–2004), and completed his Ph.D. in the College of Biomedical Science at Florida Atlantic University, Boca Raton, Florida (2004–2009). His research focuses on retinal neuroscience, including the molecular mechanisms of retinal circuit assembly, neurotransmitter receptor signaling in retinal cells, photoreceptor and non-image-forming photoreception pathways, and synaptic organization in the outer and inner retina. His most-cited publication examines the contribution of pannexin channels to afterimage signals in the amphibian retina (2025), reflecting his ongoing contributions to understanding retinal physiology and synaptic modulation.</p>
Editorial board members
Subject experts across epilepsy, neurodegeneration, stroke and neurovascular biology, neurotrauma and clinical neurophysiology. Each decision on your manuscript is signed by a named editor in the relevant field.
Professore Associato, Università di Catania, Catania, Sicilia
Gerontology Neurophysiology Brain Neuroimaging EEG Neurological Diseases Neurology Neurodegenerative Diseases Cognitive Neuroscience Neuroscience
0000-0002-8358-0885
Binzhou Medical University Hospital;John Hopkins Medicine
Neurology(Neurodegeneration or Parkinson's disease pathogenesis )
Howard University, Washington D.C., USA
Neuroscience Oxidative stress Binge drinking behavioral and cognitive deficits
Professor of Neurology, Faculty of Medicine, Kırşehir Ahi Evran University, Kırşehir, Turkey.
migraine, vertigo, and diabetic neuropaties. Her current research focuses on migraine and cognition
0000-0002-2367-1128
Thomas Jefferson University Dept. of Neuroscience, Philadelphia, US
Parkinson's disease, Spinal cord Injury, neurodegeneration, neuroprotection, axonal regeneration, axonal guidance.
Course Director, Diploma in the History of Medicine of the Society of Apothecaries (DHMSA), London.
All areas of clinical neurology Medical History.
Chair Professor, National Institute of Advanced Studies, Bengaluru, Karnataka
Cerebrovascular dysfunction in brain and retina, Vascular complications, Neuron-endothelial crosstalk
0009-0003-0279-4035
Teaching Hospital of the Paracelsus Medical Private University (PMU), Italy
EPILEPSY, EPIDEMIOLOGY, PUBLIC HEALTH, NEUROLOGY, STROKE, HISTORY OF MEDICINE
0000-0003-0928-1577
Senior Consultant, 'Agenzia Regionale di Sanità della Toscana, Firenze, Toscana
antiepileptic drugs
0000-0002-2416-147X
Henry Ford Hospital, United States
I have an interest in a wide range of physiological measurements in the brain and heart using MR Dynamic Contrast Enhanced (DCE), Single Photon Emission Computed Tomography (SPECT) imaging and Positron Emission Tomography (PET) techniques. My recent academic interests are the quantification of cerebral permeability in human and rat models of stroke and cerebral tumor using MRI contrast agents, measurement of cerebral blood flow, transfer rate, blood volume, mean transit time, arterial input function modeling, pharmacokinetic modeling, model averaging, adaptive models and applications of artificial intelligence (AI) in DCE-MRI data analyses. I am also actively working on the outcome prediction of stroke infarction from acute DCE and non-DCE MR information in human using different statistical and analytical modeling. I am familiar with brain lateralization for Epileptic patients as well as Radiotherapy Treatment (RT) planning and shielding. Since 2009, I have been studying MR quantitative biomarkers of drug efficacy for RT and anti-angiogenesis drugs in breast cancer and brain tumor patients. I have technical expertise in applied mathematics and scientific applications programming and have developed, maintained, and documented NeuroPipes, a standard suite of reconstruction, post-processing, and filtering programs for MRI data acquired on different MR consoles/machines (7T and 3T).
0000-0002-4835-9237
Professor, University of Milano-Bicocca, Milan, Lombardy
neuronal differentiation, retina physiology, channelopathies
0000-0002-7384-0401
Neuroimmunology Laboratory, School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
Immune-based therapy, Immunodiagnostic, Neuroimmunology, Age-related dementia, Protein misfolding diseases, Alzheimer's disease, Parkinson's disease, Transmissible spongiform encephalopathies, Single-domain antibodies, Camel immunology.
0000-0001-8664-6918
Professor, Houston Methodist Research Institute, Houston, TX
Genome damage response, DNA repair, Neurodegenerative diseases, Parkinson’s disease, Amyotrophic Lateral Sclerosis (ALS), Stroke
0000-0001-7333-8123
Dignity Health St Joseph Hospital and Medical Center
Alzheimer's disease, Neurodegeneration, Neurochemistry, peptides, ion channel and synaptic transmission, mitochondrial function.
Department of Anatomy and Neurobiology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
mitochondrial dysfunction
Director for Systems and Diseases-Neurology.
Epilepsy; Clinical and experimental; Human, animal and neural network modelling. Parkinson disease. Dementia. Vascular disorders. Post traumatic stress disorder. Epigenetics of neurological and psychiatric disorders.
Department of Neurosurgery, SCB Medical College, Cuttack, Odisha, India.
Neurotrauma, Neurooncology, Fungal brain diseases, Spinal disorders, Pediatric Neuroscience.
Editors are listed as recorded by the journal. Board members join and rotate over time, so this page is kept current.
Have your work judged by experts in the field
A named, subject-matter board, Single-blind (double-blind on request) peer review, and a first decision in about three weeks. Read the guidelines, then submit.